1. Home
  2. KEN vs SUPN Comparison

KEN vs SUPN Comparison

Compare KEN & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kenon Holdings Ltd.

KEN

Kenon Holdings Ltd.

HOLD

Current Price

$61.03

Market Cap

2.7B

Sector

Utilities

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$47.55

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEN
SUPN
Founded
2014
2005
Country
Singapore
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.6B
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
KEN
SUPN
Price
$61.03
$47.55
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$63.25
AVG Volume (30 Days)
10.2K
664.8K
Earning Date
12-03-2025
11-04-2025
Dividend Yield
7.83%
N/A
EPS Growth
177.70
N/A
EPS
8.96
N/A
Revenue
$803,304,000.00
$681,539,000.00
Revenue This Year
N/A
$8.32
Revenue Next Year
N/A
$23.36
P/E Ratio
$6.50
N/A
Revenue Growth
8.15
4.54
52 Week Low
$27.10
$29.16
52 Week High
$62.88
$57.65

Technical Indicators

Market Signals
Indicator
KEN
SUPN
Relative Strength Index (RSI) 60.55 54.30
Support Level $59.90 $45.36
Resistance Level $62.68 $47.26
Average True Range (ATR) 1.10 1.23
MACD -0.27 0.40
Stochastic Oscillator 60.27 91.64

Price Performance

Historical Comparison
KEN
SUPN

About KEN Kenon Holdings Ltd.

Kenon Holdings Ltd is a holding company that operates dynamic, growth-oriented businesses. The company's operating segments include OPC Power Plants, CPV Group, and ZIM. It generates maximum revenue from the OPC Power Plants segment, which generates and supplies electricity and energy in Israel. CPV Group is a limited partnership owned by OPC, which generates and supplies electricity and energy in the United States. Geographically, the company generates a majority of its revenue from Israel and the rest from the United States.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: